Multiparametric MRI for early identification of therapeutic response in recurrent glioblastoma treated with immune checkpoint inhibitorsJoseph Song, Kambiz Nael, Costas G. Hadjipanayis et al.|Neuro-Oncology|2020Cited by 44
Using EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitorsJoshua Friedman, Adı́lia Hormigo, Tomi Jun et al.|Cancer Immunology Immunotherapy|2023Cited by 9
ATIM-20. A RETROSPECTIVE STUDY EVALUATING THE SAFETY AND SURVIVAL OF THE COMBINATION OF PD-1 IMMUNE CHECKPOINT BLOCKADE AND BEVACIZUMAB IN RECURRENT GLIOBLASTOMAJoshua Friedman, Adı́lia Hormigo|Neuro-Oncology|2019Cited by 0